Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
AnaptysBio
ANAB
$655M
| $20.2K | ﹤0.01% |
816
-11,315
| -93% | -$281K |
|
1377
Cerence
CRNC
$450M
| $19.9K | ﹤0.01% |
7,241
-352,589
| -98% | -$970K |
|
1378
Scholar Rock
SRRK
$3.04B
| $19.9K | ﹤0.01% |
2,381
-10,206
| -81% | -$85.3K |
|
|
AUTL
1379
Autolus Therapeutics
AUTL
$381M
| $19.8K | ﹤0.01% |
+5,955
| New | +$19.8K |
|
1380
Arcturus Therapeutics
ARCT
$470M
| $19.7K | ﹤0.01% |
804
-14,269
| -95% | -$349K |
|
|
PETQ
1381
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $19.5K | ﹤0.01% |
881
-12,016
| -93% | -$266K |
|
|
SAGE
1382
DELISTED
Sage Therapeutics
SAGE
| $19.2K | ﹤0.01% |
1,797
-36,771
| -95% | -$393K |
|
1383
Pliant Therapeutics
PLRX
$97.6M
| $19.2K | ﹤0.01% |
+1,801
| New | +$19.2K |
|
1384
Prime Medicine
PRME
$726M
| $19.1K | ﹤0.01% |
+3,584
| New | +$19.1K |
|
1385
BILL Holdings
BILL
$5.19B
| $19K | ﹤0.01% |
362
-145,082
| -100% | -$7.63M |
|
1386
Travere Therapeutics
TVTX
$2.09B
| $18.8K | ﹤0.01% |
2,273
-47,905
| -95% | -$397K |
|
1387
Lexicon Pharmaceuticals
LXRX
$418M
| $18.8K | ﹤0.01% |
+10,792
| New | +$18.8K |
|
1388
Olema Pharmaceuticals
OLMA
$533M
| $18.7K | ﹤0.01% |
1,670
-8,869
| -84% | -$99.4K |
|
1389
IPG Photonics
IPGP
$3.38B
| $18.7K | ﹤0.01% |
224
-30,451
| -99% | -$2.54M |
|
1390
VEON
VEON
$3.71B
| $18.6K | ﹤0.01% |
+720
| New | +$18.6K |
|
|
CHCT
1391
Community Healthcare Trust
CHCT
$445M
| $18.5K | ﹤0.01% |
798
-10,225
| -93% | -$237K |
|
1392
UroGen Pharma
URGN
$869M
| $18.3K | ﹤0.01% |
+1,079
| New | +$18.3K |
|
1393
Wave Life Sciences
WVE
$1.11B
| $18.2K | ﹤0.01% |
+3,656
| New | +$18.2K |
|
1394
Phathom Pharmaceuticals
PHAT
$840M
| $18.2K | ﹤0.01% |
1,748
-12,158
| -87% | -$126K |
|
|
INN
1395
Summit Hotel Properties
INN
$623M
| $18K | ﹤0.01% |
3,099
-42,890
| -93% | -$250K |
|
1396
Erasca
ERAS
$443M
| $17.9K | ﹤0.01% |
+7,758
| New | +$17.9K |
|
1397
Zymeworks
ZYME
$1.19B
| $17.8K | ﹤0.01% |
+2,111
| New | +$17.8K |
|
1398
SPDR Blackstone Senior Loan ETF
SRLN
$6.96B
| $17.7K | ﹤0.01% |
+424
| New | +$17.7K |
|
|
HPP
1399
Hudson Pacific Properties
HPP
$1.11B
| $17.6K | ﹤0.01% |
+3,658
| New | +$17.6K |
|
1400
Arbutus Biopharma
ABUS
$855M
| $17.5K | ﹤0.01% |
+5,634
| New | +$17.5K |
|